Cuprina Holdings (Cayman) Limited (CUPR)
Nasdaq: CUPR · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Singapore, SG · filing with the SEC since 2023
Income statement, as filed
In Singapore dollars (SGD), as filed; per-share figures in Singapore dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Apr 27, 2026 | May 14, 2025 | · | · |
| Revenue | 49,894 | 48,321 | 100,773 | 56,599 |
| For lenders | ||||
| Net interest income | -14,724 | -37,210 | -56,587 | -2,017 |
| Provision for credit losses | -3,807 | -2,112 | 106 | -2,935 |
| Cost of revenue | 50,539 | 51,345 | 64,168 | 36,621 |
| Gross profit | -645 | -3,024 | 36,605 | 19,978 |
| Research and development | 226,884 | 241,362 | 167,734 | 292,879 |
| Selling, general and administrative | 4,602,300 | 1,400,873 | 937,200 | 902,887 |
| Total operating expenses | 4,829,184 | 1,642,235 | 1,104,934 | 1,195,766 |
| Operating income | -4,829,829 | -1,645,259 | -1,068,329 | -1,175,788 |
| Interest expense | 14,724 | 1,783 | 727 | 1,842 |
| Total non-operating income (expense) | 219,731 | 136,655 | -17,438 | 88,617 |
| Income before income taxes | -4,610,098 | -1,508,604 | -1,085,767 | -1,087,171 |
| Net income including non-controlling interests | -4,673,447 | -1,560,535 | -1,119,555 | -1,094,516 |
| Net income | -4,673,447 | -1,560,535 | -1,119,555 | -1,094,516 |
| Earnings per share, basic | -22.83 | -8.68 | -6.22 | -6.08 |
| Earnings per share, diluted | -22.83 | -8.68 | -6.22 | -6.08 |
| Weighted average shares, basic | 20,471,507 | 18,000,000 | 18,000,000 | 18,000,000 |
| Weighted average shares, diluted | 20,471,507 | 18,000,000 | 18,000,000 | 18,000,000 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetProvision for credit losses set aside for loans that may not be repaid
us-gaap:ProvisionForLoanLeaseAndOtherLossesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding